Table 4.
Results obtained by SeptiFast and blood culture among patients receiving or not receiving antimicrobial therapy
| Ward and antimicrobial therapy | No. of samplesa |
|||
|---|---|---|---|---|
| SeptiFast/blood culture positive | SeptiFast positive/blood culture negative | SeptiFast negative/blood culture positiveb | Total | |
| Intensive care, surgery | ||||
| Yes | 26 | 34 | 4 | 64 |
| No | 31 | 6 | 2 | 39 |
| Oncology, hematology, neonatology | ||||
| Yes | 15 | 23 | 6 | 44 |
| No | 25 | 6 | 5 | 36 |
| Emergency department, pediatrics | ||||
| Yes | 9 | 26 | 1 | 36 |
| No | 37 | 2 | 1 | 40 |
a
The total numbers of pathogens from patients under antimicrobial therapy/patients not under antimicrobial therapy for the SeptiFast-positive plus blood culture-positive, SeptiFast-positive and blood culture-negative, and SeptiFast-negative and blood culture-positive groups were 50/93, 83/14, and 11/8, respectively (total, 144/115).
b
Including microorganisms not in the SML.